Michael Cusick, MD
Retina Specialist · Charlottesville, VANPI 1275670291
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (43.9%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Stryker at 43.9% of the total. Reporting peaked in 2019 at $810 and has fallen 81.5% since, to $150 in 2024. That places this record below the midpoint for retina specialist clinicians in VA, where the typical reported total is $1,967.
Across 17 payments — averaging $97.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$725
- Vertex$480
- Cardinal Health 110 LLC$150
- Regeneron Healthcare Solutions, Inc.$106
- AbbVie$84
- Genentech USA, Inc.$73
- plus $32 from 2 others
Across 1 payment — averaging $3000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Roche TCRC, Inc.$3K
What the payments were for
- Consulting fees$65540%
- Travel & lodging$72544%
- Food & beverage$25115%
- Gifts$191%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 1 | $725 |
| Vertex | 1 | $480 |
| Cardinal Health 110 LLC | 1 | $150 |
| Regeneron Healthcare Solutions, Inc. | 5 | $106 |
| AbbVie(2 entities) | 3 | $84 |
| Genentech USA, Inc. | 4 | $73 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Novartis | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,651 in reported general payments places this provider in the 35th percentile of 41 retina specialist providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XiidraLifitegrast | 13 | $9,027 |
| Difluprednate | 29 | $5,589 |
| ProlensaBromfenac Sodium | 14 | $5,051 |
| Bromfenac Sodium | 39 | $4,798 |
| Prednisolone Acetate | 57 | $1,917 |
| Ketorolac Tromethamine | 37 | $697 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 18 | $315 |
| ErythromycinErythromycin Base | 19 | $136 |
| Dorzolamide Hcl | 14 | $135 |
| Brimonidine Tartrate | 18 | $60 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Charlottesville
- Mohit NandaCharlottesville$31K
- Hayley JamesCharlottesville$5K
- Jacob MeyerCharlottesville$2K
- Jordana FeinManassas$412K
- Joaquin TosiVirginia Beach$48K
- Muge KesenMc Lean$30K
- Anna MackinRoanoke$26K
- Jon AdlebergChesapeake$21K
- Dal ChunVienna$12K
- Kori ElkinsPortsmouth$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.